Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer

BJU International

Volumn 114, Issue 3, 2014, Pages 389-395

  Goodfellow, Henry ^a   Viney, Zaid ^b   Hughes, Paul ^b   Rankin, Sheila ^b   Rottenberg, Giles ^b   Hughes, Simon ^b   Evison, Felicity ^c   Dasgupta, Prokar ^d   O'Brien, Timothy ^b   Khan, Muhammad Shamim ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

bladder cancer; cystectomy; FDG PET CT; positron emission tomography; preoperative staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BIOPSY; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER STAGING; COLON ADENOMA; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; FEMALE; FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; NON MUSCLE INVASIVE BLADDER CANCER; PAROTID GLAND CARCINOMA; PELVIS LYMPH NODE; PELVIS RADIOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY;

BLADDER CANCER; CYSTECTOMY; FDG PET/CT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE STAGING;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; CYSTECTOMY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM STAGING; PATIENT SELECTION; PELVIS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THORAX; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER NEOPLASMS;

EID: 84906935218     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12608     Document Type: Article

References (26)

1. Bouchelouche K, Turkbey B, Choyke PL,. PET/CT and MRI in bladder cancer. J Cancer Sci Ther 2012; S14: pii: 7692
2. Rozanski TA, Grossman HB,. Recent developments in the pathophysiology of bladder cancer. AJR Am J Roentgenol 1994; 163: 789-792 (Pubitemid 24313133)
3. Bischoff CJ, Clark PE,. Bladder cancer. Curr Opin Oncol 2009; 21: 272-277
4. Schumacher MC, Jonsson MN, Wiklund NP,. Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer? Curr Opin Oncol 2009; 19: 527-532
5. Stein JP, Skinner DG,. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin North Am 2005; 32: 187-197 (Pubitemid 40603293)
6. Stenzl A, Cowan NC, De Santis M, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011; 59: 1009-1018
7. Karl A, Carroll PR, Gschwend JE, et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 2009; 55: 826-835
8. Sherif A, Holmberg L, Rintala E, et al. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies. Eur Urol 2004; 45: 297-303 (Pubitemid 38221402)
9. Tritschler S, Mosler C, Straub J, et al. Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? World J Urol 2012; 30: 827-831
10. Shariat SF, Palapattu GS, Karakiewicz PI, et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 2007; 51: 137-151 (Pubitemid 44821508)
11. Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009; 55: 761-769
12. Swinnen G, Maes A, Pottel H, et al. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 2010; 57: 641-647
13. Kibel AS, Dehdashti F, Katz MD, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 2009; 27: 4314-4320
14. Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L,. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 2005; 32: 1412-1417 (Pubitemid 41746845)
15. Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y,. Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 2010; 106: 658-663
16. Jensen TK, Holt P, Gerke O, et al. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol 2011; 45: 122-128
17. Herr H, Lee C, Chang S, Lerner S, Bladder Cancer Collaborative G. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 2004; 171: 1823-1828
18. Frank I, Cheville JC, Blute ML, et al. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome. Cancer 2003; 97: 2425-2431 (Pubitemid 36542481)
19. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-675 (Pubitemid 32120143)
20. Stein JP, Skinner DG,. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol 2006; 24: 296-304 (Pubitemid 44143761)
21. Vieweg J, Gschwend JE, Herr HW, Fair WR,. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999; 161: 449-454
22. Kassouf W, Agarwal PK, Grossman HB, et al. Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology 2009; 73: 147-152
23. Golan S, Sopov V, Baniel J, Groshar D,. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study. J Urol 2011; 186: 436-441
24. Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE,. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. J Nucl Med 2007; 48: 764-770 (Pubitemid 47604977)
25. Kobayashi S, Koga F, Yoshida S, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011; 21: 2178-2186
26. Deserno WM, Harisinghani MG, Taupitz M, et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004; 233: 449-456 (Pubitemid 39423804)